Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
POLR3A-related disorders: expanding the clinical phenotype.
McKenna MC, O'Connor A, Lockhart A, Bogdanova-Mihaylova P, Brett F, Langan Y, Meaney J, Costigan D, Doherty CP, Bede P, Murphy SM, Hutchinson S. McKenna MC, et al. Among authors: costigan d. J Neurol. 2024 Jun;271(6):3635-3638. doi: 10.1007/s00415-024-12265-9. Epub 2024 Feb 27. J Neurol. 2024. PMID: 38413463 No abstract available.
P53 and TLR4 expression are prognostic markers informing progression free survival of advanced stage high grade serous ovarian cancer.
Bates M, Mullen D, Lee E, Costigan D, Heron EA, Kernan N, Barry-O'Crowley J, Martin C, Keegan H, Malone V, Brooks RD, Brooks DA, Logan JM, Martini C, Selemidis S, McFadden J, O'Riain C, Spillane CD, Gallagher MF, McCann A, O'Toole S, O'Leary JJ. Bates M, et al. Among authors: costigan d. Pathol Res Pract. 2024 Jan;253:155020. doi: 10.1016/j.prp.2023.155020. Epub 2023 Dec 7. Pathol Res Pract. 2024. PMID: 38103365 Free article.
A pro-inflammatory gut mucosal cytokine response is associated with mild COVID-19 disease and superior induction of serum antibodies.
Costigan D, Fenn J, Yen S, Ilott N, Bullers S, Hale J, Greenhalf W, Conibear E, Koycheva A, Madon K, Jahan I, Huang M, Badhan A, Parker E, Rosadas C, Jones K, McClure M, Tedder R, Taylor G, Baillie KJ, Semple MG, Openshaw PJM, Pearson C, Johnson J; INSTINCT Study Group; ISARIC4C investigators; Lalvani A, Thornton EE. Costigan D, et al. Mucosal Immunol. 2024 Feb;17(1):111-123. doi: 10.1016/j.mucimm.2023.11.005. Epub 2023 Nov 22. Mucosal Immunol. 2024. PMID: 37995912 Free PMC article.
Late-onset Tay-Sachs disease presenting with a neuromuscular phenotype-a case series.
Fullam S, Togher Z, Power A, Kennelly L, McHugh JC, O'Dowd S, Tubridy N, Hardiman O, Costigan D, Ryan A, Lefter S, Connolly S, Murphy SM. Fullam S, et al. Among authors: costigan d. Eur J Neurol. 2024 Jan;31(1):e16069. doi: 10.1111/ene.16069. Epub 2023 Sep 27. Eur J Neurol. 2024. PMID: 37754769 Free PMC article.
A conserved population of MHC II-restricted, innate-like, commensal-reactive T cells in the gut of humans and mice.
Hackstein CP, Costigan D, Drexhage L, Pearson C, Bullers S, Ilott N, Akther HD, Gu Y, FitzPatrick MEB, Harrison OJ, Garner LC, Mann EH, Pandey S, Friedrich M, Provine NM, Uhlig HH, Marchi E, Powrie F, Klenerman P, Thornton EE. Hackstein CP, et al. Among authors: costigan d. Nat Commun. 2022 Dec 3;13(1):7472. doi: 10.1038/s41467-022-35126-3. Nat Commun. 2022. PMID: 36463279 Free PMC article.
Correlation of integrated ERG/PTEN assessment with biochemical recurrence in prostate cancer.
Brady L, Carlsson J, Baird AM, Casey O, Vlajnic T, Murchan P, Cormican D, Costigan D, Gray S, Sheils O, O'Neill A, Watson RW, Andren O, Finn S. Brady L, et al. Among authors: costigan d. Cancer Treat Res Commun. 2021;29:100451. doi: 10.1016/j.ctarc.2021.100451. Epub 2021 Sep 2. Cancer Treat Res Commun. 2021. PMID: 34507017 Free article.
60 results